#TaibaRare #RareMetabolicDisease #PatientAwareness #LipodystrophyAwareness #RareDisease #MetabolicHealth #WorldLipodystrophyDay #RareDisorders #ChronicIllness To view or add a comment, sign in Ashley Shoemaker, MD, MSci, of Vanderbilt Health discusses the FDA approval of setmelanotide (Imcivree), the first targeted therapy for acquired hypothalamic obesity in patients 4+ years
This natural hormone plays several key roles: it helps you feel full, signals the pancreas to produce and release insulin, and assists in regulating blood sugar levels
Hyperhomocysteinemia and risk of incident cognitive outcomes: An updated dose-response meta-analysis of prospective cohort studies
Understanding the specific cellular pathways and molecular targets could guide future drug development efforts
For a broader survey of published preclinical findings and study design considerations, the BPC-157 research overview consolidates the current experimental landscape
The accumulation of RS contributes to functional decline and age-related diseases such as cardiovascular diseases, neurodegenerative disorders, and cancer [13]